About Biotavia Pharm Private Limited
Data last updated:
Biotavia Pharm Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 July 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2006PTC150738. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.49 Cr. It was formerly known as Zeneses Bioresearch Limited and Zeneses Bioresearch Limited. It is led by directors Vipul Goel and Sameer Goel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 974 Aggarwal Millenium Tower II Netaji Subhash Place Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2023, the company reported a revenue of ₹11,300. For the same year it recorded a net loss of ₹3.77 Lakh and EBITDA of -₹1.65 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 92% over three years and 84% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biotavia.com.
Company details
Name history
Biotavia Pharm has undergone 3 name changes throughout its history. The company was previously known as Zeneses Bioresearch Limited, Zeneses Bioresearch Limited, and Zeneses Bioresearch Private Limited. The current legal name is Biotavia Pharm Private Limited.
| Company Name | Status |
|---|---|
| Biotavia Pharm Private Limited | Current |
| Zeneses Bioresearch Limited | Previous |
| Zeneses Bioresearch Limited | Previous |
| Zeneses Bioresearch Private Limited | Previous |
CIN history
Biotavia Pharm has one previous CIN (Corporate Identification Number): U24233DL2006PLC150738. The current CIN is U24233DL2006PTC150738, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233DL2006PTC150738 | Current |
| U24233DL2006PLC150738 | Previous |
Contact details
Biotavia Pharm Private Limited's registered office is in Delhi, Delhi. Its website is biotavia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address974 Aggarwal Millenium Tower II Netaji Subhash Place Pitampura, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Biotavia Pharm Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Biotavia Pharm Private Limited
FY 2025 filings availableBiotavia Pharm Private Limited reported revenue of ₹11,300 for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 84% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹11,300 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.77 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biotavia Pharm Private Limited, buy the company report.
Board of directors of Biotavia Pharm Private Limited
Biotavia Pharm has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vipul Goel Also directs: Zeneses Biosciences Private Limited, Actaviaa Biotech Private Limited, Biowia Biotech Private Limited and 1 more | Director | 09 Jul 2006 | 20 Years 3 Months | Current |
| Sameer Goel Also directs: Zeneses Biosciences Private Limited, Actaviaa Biotech Private Limited, Biowia Biotech Private Limited and 3 more | Director | 05 Jul 2021 | 5 Years 3 Months | Current |
Auditor
Biotavia Pharm Private Limited is audited by RAVI VARSHNEY & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVI VARSHNEY & ASSOCIATES | FY 2023 | 517363 |
Shareholding
The shareholding of Biotavia Pharm Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Biotavia Pharm Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biotavia Pharm Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biotavia Pharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Biotavia Pharm Private Limited has a workforce of 2 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
GST
Biotavia Pharm has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Biotavia Pharm Private Limited, buy the company report.
Recent activity
Biotavia Pharm Private Limited has 6 board changes on record since 2006: 2 appointments and 4 cessations. The latest: Vinod Prakash ceased to be Director on 20 Oct 2022.
Frequently asked questions
Biotavia Pharm is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 July 2006 (20+ years old) and is registered under CIN U24233DL2006PTC150738.
Biotavia Pharm has 2 current directors:
- Vipul Goel - Director
- Sameer Goel - Director
The latest financial statements of Biotavia Pharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Biotavia Pharm has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Biotavia Pharm is U24233DL2006PTC150738. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biotavia Pharm was incorporated on 09 July 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Vinod Prakash ceased to be Director on 20 Oct 2022. Sameer Goel ceased to be Additional Director on 30 Nov 2021. Sameer Goel was appointed as Director on 05 Jul 2021. Biotavia Pharm has 6 board changes on record in total.
Biotavia Pharm can be reached through the website biotavia.com. Its registered office is in Delhi, India.
The registered office of Biotavia Pharm is at 974 Aggarwal Millenium Tower II Netaji Subhash Place Pitampura, Delhi, India – 110034.
Biotavia Pharm operates in the pharma industry, in the drug formulation and development segment.